Article Details

No OS Difference Among First-Line CDK4/6 Inhibitors in HR+/HER2- mBC

Retrieved on: 2024-12-12 19:17:48

Tags for this article:

Click the tags to see associated articles and topics

No OS Difference Among First-Line CDK4/6 Inhibitors in HR+/HER2- mBC. View article details on hiswai:

Excerpt

The retrospective P-VERIFY study (NCT06495164) used the US nationwide Flatiron Health electronic health record-derived deidentified panoramic ...

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo